$1.64
(3.46%)
Add to watchlist
Create an alert
Stocks and Shares ISADirector deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 23 February 2026 | Mohammed (Mo) QatananiChief Level Officer | Sell Option/Award related | 7,427 | $46.94 | $348,639.72 | 99,502 |
| 23 February 2026 | Mohammed (Mo) QatananiChief Level Officer | Sell Option/Award related | 857 | $47.86 | $41,014.99 | 98,645 |
| 23 February 2026 | Mohammed (Mo) QatananiChief Level Officer | Sell Option/Award related | 200 | $48.48 | $9,696.00 | 98,445 |
| 17 February 2026 | Junlin HoGeneral Counsel | Sell Tax related | 9,580 | $46.53 | $445,740.16 | 241,545 |
| 17 February 2026 | Caryn ParlavecchioGroup Director | Sell Tax related | 9,035 | $46.53 | $420,382.29 | 169,087 |
| 17 February 2026 | Jing L MarantzOther Level A | Sell Tax related | 4,157 | $46.53 | $193,417.73 | 126,012 |
| 17 February 2026 | Mohammed (Mo) QatananiChief Level Officer | Sell Tax related | 7,989 | $46.53 | $371,713.79 | 106,929 |
| 22 January 2026 | Mohammed (Mo) QatananiChief Level Officer | Sell Option/Award related | 2,119 | $45.87 | $97,188.99 | 98,439 |
| 22 January 2026 | Mohammed (Mo) QatananiChief Level Officer | Sell Option/Award related | 12,779 | $46.85 | $598,748.54 | 85,660 |
| 16 January 2026 | Junlin HoGeneral Counsel | Sell Tax related | 8,016 | $44.48 | $356,533.24 | 214,553 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 3 October 2025 | SAMSARA BIOCAPITAL GP LLCPrivate Equity | Buy Regular purchase transaction | 319,700 | $37.42 | $11,963,174.00 | 387,414 |
| 4 December 2025 | Mohammed (Mo) QatananiChief Level Officer | Sell Option/Award related | 136,462 | $45.21 | $6,169,788.18 | 108,964 |
| 10 March 2025 | Edward H MylesCFO | Sell Option/Award related | 112,897 | $35.82 | $4,043,970.54 | 140,740 |
| 6 October 2025 | SAMSARA BIOCAPITAL GP LLCPrivate Equity | Buy Regular purchase transaction | 80,863 | $38.68 | $3,127,780.84 | 486,691 |
| 13 January 2026 | David L. HallalChairman/CEO | Sell Tax related | 57,450 | $42.70 | $2,453,115.00 | 1,541,645 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.